市场调查报告书
商品编码
1535179
硬脑膜替代市场:各市场区隔规模,占有率,法律规章,偿付,手术,2033年为止的预测Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
硬脑膜材料是用来修復硬脑膜的片材或材质的补片。闭合或修復硬脑膜对于防止脑脊髓液(CSF)渗漏至关重要。本部分追踪生物和合成硬脑膜替代品。
硬脑膜撕裂是开颅手术和脊椎融合手术的风险。修復不充分会导致脑脊髓液漏、感染和神经损伤。小的撕裂可以透过止血来闭合,但较大的撕裂需要硬脑膜替代物。硬脑膜替代物在开颅手术中比在脊椎介入治疗中更常用。
本报告提供全球硬脑膜替代市场相关资料详细考察,提供市场上竞争情形,SWOT分析,到2033年为止的市场预测,地区,各国的趋势等资讯。
Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.
These are patches which are used as sheet or material in repairing the dura mater. Closure or repair of dura mater is essential to prevent a cerebrospinal fluid (CSF) leak. Biological dura substitutes and synthetic dura substitutes are tracked under this segment.
Dural tears are a risk in craniotomy and spinal fusion surgeries. Inadequate repair can lead to cerebrospinal fluid leakage, infection, and neurological deficits. Small tears are closed watertight, while larger ones require dura substitutes. Dura substitutes are more commonly used in craniotomy procedures than in spinal interventions.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Dura Substitutes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Integra LifeSciences Corp, B. Braun Melsungen AG, Medtronic Plc, DePuy Synthes Inc, Regenity Biosciences, Baxter International Inc and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -